tiprankstipranks
Trending News
More News >
Neurocrine Biosciences (NBIX)
:NBIX

Neurocrine (NBIX) Revenue

Compare
1,394 Followers

Neurocrine Revenue

Neurocrine had a revenue of 572.60M in the quarter ending Mar 31, 2025, with -8.78%. This bring the company's revenue in the last twelve months to 2.41B, Decreased 2.43%. In the fiscal year ending Dec 31, 2024, Neurocrine had annual revenue of 2.36B with 24.81% growth.
Revenue (ttm)
2.41B
Revenue Growth
21.73%
P/S Ratio
5.25
Revenue/Employee
$1,308,500
Employees
1,800
Market Cap
$12.37B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
2.36B468.20M+24.81%
Dec 31, 2023
1.89B398.40M+26.76%
Dec 31, 2022
1.49B355.20M+31.34%
Dec 31, 2021
1.13B87.60M+8.38%
Dec 31, 2020
1.05B257.80M+32.71%
Dec 31, 2019
788.10M336.86M+74.65%
Dec 31, 2018
451.24M289.61M+179.19%
Dec 31, 2017
161.63M146.63M+977.51%
Dec 31, 2016
15.00M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis